A detailed history of Nordea Investment Management Ab transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Nordea Investment Management Ab holds 96,356 shares of TEVA stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96,356
Previous 91,837 4.92%
Holding current value
$1.69 Million
Previous $1.49 Million 16.35%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$15.81 - $18.96 $71,445 - $85,680
4,519 Added 4.92%
96,356 $1.74 Million
Q1 2024

May 02, 2024

BUY
$10.67 - $14.43 $28,819 - $38,975
2,701 Added 3.03%
91,837 $1.3 Million
Q4 2023

Jan 10, 2024

BUY
$8.12 - $10.63 $12,350 - $16,168
1,521 Added 1.74%
89,136 $930,000
Q3 2023

Nov 13, 2023

SELL
$7.48 - $10.7 $976,686 - $1.4 Million
-130,573 Reduced 59.84%
87,615 $893,000
Q2 2023

Jul 07, 2023

SELL
$7.2 - $9.47 $145,051 - $190,782
-20,146 Reduced 8.45%
218,188 $1.64 Million
Q1 2023

Apr 19, 2023

BUY
$8.36 - $11.37 $32,252 - $43,865
3,858 Added 1.65%
238,334 $2.11 Million
Q4 2022

Feb 08, 2023

BUY
$7.95 - $9.48 $1.3 Million - $1.54 Million
162,970 Added 227.91%
234,476 $2.14 Million
Q3 2022

Oct 19, 2022

SELL
$6.86 - $11.95 $68,730 - $119,727
-10,019 Reduced 12.29%
71,506 $570,000
Q2 2022

Aug 09, 2022

BUY
$7.38 - $10.4 $118,862 - $167,502
16,106 Added 24.62%
81,525 $620,000
Q4 2021

Jan 20, 2022

BUY
$7.9 - $10.19 $40,337 - $52,030
5,106 Added 8.47%
65,419 $533,000
Q3 2021

Nov 01, 2021

BUY
$8.38 - $10.18 $505,422 - $613,986
60,313 Added 100.0%
120,626 $1.17 Million
Q3 2021

Nov 01, 2021

SELL
$8.38 - $10.18 $505,422 - $613,986
-60,313 Reduced 50.0%
60,313 $597,000
Q1 2021

May 17, 2021

SELL
$10.34 - $12.81 $534,960 - $662,750
-51,737 Reduced 46.17%
60,313 $687,000
Q3 2020

Nov 09, 2020

SELL
$8.57 - $12.69 $824,211 - $1.22 Million
-96,174 Reduced 46.19%
112,050 $1.02 Million
Q2 2020

Aug 13, 2020

BUY
$8.12 - $13.12 $882,765 - $1.43 Million
108,715 Added 109.25%
208,224 $2.57 Million
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $19,171 - $37,114
-2,361 Reduced 2.32%
99,509 $919,000
Q1 2019

May 20, 2019

BUY
$15.58 - $20.01 $33,839 - $43,461
2,172 Added 2.18%
101,870 $1.6 Million
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $2,757 - $4,505
189 Added 0.19%
99,698 $1.54 Million
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $2.1 Million - $2.55 Million
99,509 New
99,509 $2.14 Million
Q2 2018

Aug 13, 2018

SELL
$16.77 - $24.71 $1.22 Million - $1.8 Million
-72,824 Closed
0 $0
Q4 2017

Feb 12, 2018

SELL
$11.23 - $19.1 $1.15 Million - $1.96 Million
-102,553 Reduced 58.48%
72,824 $1.38 Million
Q3 2017

Nov 09, 2017

BUY
$15.41 - $32.17 $2.7 Million - $5.64 Million
175,377
175,377 $3.09 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.